Click a link below to view the mailing archive as if it had been sent to you.
| 2023-05-31 12:15 | | Biopharma Layoff Tracker 2023: Rain Oncology, Takeda, PTC and more cut staff and more... |
| 2023-05-31 00:15 | | Alnylam sticks with aggressive litigation strategy against Pfizer and Moderna, filing yet another patent lawsuit and more... |
| 2023-05-30 12:15 | | Persistent Sun Pharma ready to complete Taro buyout—16 years after initial offer and more... |
| 2023-05-30 00:15 | | Gilead, Teva reach 11th-hour settlements with some groups in HIV antitrust case and more... |
| 2023-05-26 12:15 | | FDA grants priority review for Takeda and HUTCHMED’s fruquintinib NDA and more... |
| 2023-05-26 00:15 | | ASCO puts spotlight on advancing antibody-drug conjugate pipeline and more... |
| 2023-05-25 12:15 | | Illumina, Icahn prepare for proxy showdown |
| 2023-05-25 00:15 | | Mirati's long wait for next lung cancer med ends in phase 3 failure and more... |
| 2023-05-24 12:15 | | FTC probes Abbott for allegedly colluding on bids for state contracts and more... |
| 2023-05-24 00:15 | | Bayer, Amgen looked at Iveric before agreeing to Astellas sale and more... |
| 2023-05-23 12:15 | | Wave's ALS-dementia drug crashes out after early-phase flop, dealing further blow to target and more... |
| 2023-05-23 00:15 | | New nasal spray to reverse fentanyl and other opioid overdoses gets FDA approval and more... |
| 2023-05-22 12:15 | | Novo Nordisk pauses Wegovy marketing projects to dampen demand and more... |
| 2023-05-22 00:15 | | Future of Intercept’s NASH drug in doubt after FDA panel rejection and more... |
| 2023-05-19 12:15 | | On heels of Amgen lawsuit, FTC broadens investigation of PBMs and more... |
| 2023-05-19 00:15 | | FDA advisory panel backs Pfizer’s RSV vaccine, but expresses some safety concerns and more... |
| 2023-05-18 12:15 | | Supreme Court rules against Amgen bid to revive cholesterol drug patents and more... |
| 2023-05-18 00:15 | | FDA staff unsure NASH drug’s ‘modest’ benefits outweigh safety risks and more... |
| 2023-05-17 12:15 | | Pharma, patient advocates clash over Inflation Reduction Act and more... |
| 2023-05-17 00:15 | | Amgen ‘Remains Committed’ to $27.8B Horizon Acquisition After FTC Challenge and more... |
| 2023-05-16 12:15 | | Drug Farm Raises $27M USD Financing for Advancement of First-In-Class Hepatitis B and Cardiovascular-Renal Drugs into Clinical Trials and more... |
| 2023-05-16 00:15 | | SCOTUS Kills Hope for Eligibility Certainty and Nixes Teva’s ‘Skinny Label’ Appeal and more... |
| 2023-05-15 12:15 | | Pfizer, Seagen kick off antitrust review of $43B merger. Will FTC get on board? and more... |
| 2023-05-12 12:15 | | Senate health committee seeks to rein in drug prices with four new bills and more... |
| 2023-05-12 00:15 | | Codagenix initiates new study of live-attenuated vaccine in RSV and more... |
| 2023-05-11 12:15 | | Alzheimer’s doctors see promise, limits in Lilly’s latest drug data and more... |
| 2023-05-11 00:15 | | Teva CEO Richard Francis, after 4 months at the helm, preps grand strategic reveal and more... |
| 2023-05-10 12:15 | | Zealand, Boehringer's drug meets main weight-loss goal in mid-stage trial and more... |
| 2023-05-10 00:15 | | Samsung gets FDA clearance for irregular heart notification feature, catching up with Apple and Fitbit and more... |
| 2023-05-09 12:15 | | Roche, with HER2 franchise under pressure, pays $70M for breast cancer brain metastases prospect and more... |
| 2023-05-09 00:15 | | So you think you can go public? Few biotechs dance with Wall Street and more... |
| 2023-05-08 12:15 | | BMS Cuts Jobs in New Jersey, Cites ‘Constantly Evolving’ Business Model and more... |
| 2023-05-08 00:15 | | AstraZeneca, Pfizer Top 2023 Pharma List for Invention and Innovation and more... |
| 2023-05-06 00:15 | | Biogen, Novartis, Sanofi Cull Candidates in Q1 Pipeline Reprioritizations and more... |
| 2023-05-05 12:15 | | Boehringer Ingelheim to surf with Melbourne-based biotech in $181M neuropsychiatric therapy deal and more... |
| 2023-05-05 00:15 | | Amid high demand, Novo Nordisk temporarily throttles US supply of low-dose Wegovy and more... |
| 2023-05-04 12:15 | | Revenues down for Moderna, up for Regeneron in Q1 and more... |
| 2023-05-04 00:15 | | FDA approves first RSV vaccine, clearing GSK’s Arexvy for older adults and more... |
| 2023-05-03 12:15 | | Lilly drug slows Alzheimer’s decline in large study and more... |
| 2023-05-03 00:15 | | Bristol Myers accuses AstraZeneca of infringing patent on cancer blockbuster Opdivo—again and more... |
| 2023-05-02 12:15 | | Pfizer reports strong Q1 earnings, including $18.3B in revenues and more... |
| 2023-05-02 00:15 | | One-third of US nurses plan to quit profession - report and more... |
| 2023-05-01 12:15 | | Astellas to acquire eye drug developer Iveric Bio for $5.9B and more... |
